Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 12Non-Muscle Invasive Bladder Neoplasms 9Carcinoma, Transitional Cell 7Stomach Neoplasms 4Anus Neoplasms 4Pancreatic Neoplasms 3Carcinoma, Hepatocellular 3Peritoneal Neoplasms 2Liver Neoplasms 2Colorectal Neoplasms 2Appendiceal Neoplasms 2Urologic Neoplasms 1Urologic Diseases 1Urogenital Neoplasms 1Urinary Bladder Diseases 1Urethral Neoplasms 1Ureteral Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Pseudomyxoma Peritonei 1Neoplasms by Site 1Neoplasms 1Neoplasm Recurrence, Local 1Neoplasm Metastasis 1Mycobacterium Infections 1Gastrointestinal Neoplasms 1Dermatitis 1Carcinoma in Situ 1Carcinoma 1Anal Canal Carcinoma 1Adenocarcinoma 1

Interventions

Gemcitabine 5Cisplatin 4enfortumab vedotin 2Ramucirumab 2Platinum 2Docetaxel 21,2-diaminocyclohexaneplatinum II citrate 2vinflunine 1rucaparib 1pembrolizumab 1eribulin 1enzalutamide 1dehydroftorafur 1carotuximab 1avelumab 1atezolizumab 1Standard of Care 1Specimen Handling 1Radiotherapy 1Radiation 1Paclitaxel 1N-(3-aminopropyl)-N-(1-(5-benzyl-3-methyl-4-oxo-(1,2)thiazolo(5,4-d)pyrimidin-6-yl)-2-methylpropyl)-4-methylbenzamide 1Mitozytrex 1Mitomycin 1Magnetic Resonance Spectroscopy 1Interleukin-7 1Immunoglobulin G 1Icrucumab 1IMC-18F1 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Ureteral Neoplasms × Mitomycin × Clear all
NCT03617913 2023-01-06

Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer

Mayo Clinic

Phase 2 Completed
2 enrolled 8 charts
Genitourinary

Urinary Bladder Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡